Glycinergic potentiation by some 5-HT3 receptor antagonists: Insight into selectivity

European Journal of Pharmacology

Volumn 402, Issue 3, 2000, Pages 205-213

  Chesnoy Marchais, Dominique ^a   Lévi, Sabine ^b   Acher, Francine ^c  

^a CNRS   (France)

^b INSERM   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

5 HT3 receptor antagonist; Glycine receptor; Interaction; Pharmacophore model; Potentiation; Selectivity

Indexed keywords

1 METHYL 3 INDAZOLECARBOXYLIC ACID N TROPANYLAMIDE; BEMESETRON; COCAINE; GLYCINE; GLYCINE RECEPTOR; GRANISETRON; SEROTONIN 3 ANTAGONIST; TROPISETRON; ZACOPRIDE; ZATOSETRON;

ANIMAL TISSUE; ARTICLE; DRUG POTENTIATION; DRUG SELECTIVITY; DRUG STRUCTURE; ELECTROPHYSIOLOGY; EMBRYO; MOLECULAR MODEL; NONHUMAN; PHARMACOPHORE; PRIORITY JOURNAL; RAT; TISSUE CULTURE; VENTRAL ROOT;

ANIMALS; GLYCINE; MODELS, MOLECULAR; MOTOR NEURONS; PATCH-CLAMP TECHNIQUES; RATS; RECEPTORS, GLYCINE; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT3; SEROTONIN ANTAGONISTS; SPINAL CORD; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0343391169     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00531-8     Document Type: Article

References (32)

1. Becker C.-M., Langosch D. The inhibitory glycine receptor. Stephenson F.A., Turner A.J. Amino Acid Neurotransmission. 1998;93-112 Portland, London.
2. Bessis A.-S., Jullian N., Coudert E., Pin J.-P., Acher F. Extended glutamate activates metabotropic receptor types 1, 2 and 4: selective features at mGluR4 binding site. Neuropharmacology. 38:1999;1543-1551.
3. 3 receptor using site directed mutagenesis: importance of glutamate 106. Neuropharmacology. 36:1997;637-647.
4. 3 antagonists in rat spinal neurones. Br. J. Pharmacol. 118:1996;2115-2125.
5. Chesnoy-Marchais D. Mode of action of ICS 205,930, a novel type of potentiator of responses to glycine in rat spinal neurones. Br. J. Pharmacol. 126:1999;801-809.
6. Chesnoy-Marchais D., Supplisson S. The glycine receptor beta subunit is required for the potentiation of glycine responses by low concentrations of ICS 205,930. Soc. Neurosci. Abs. 25:1999;457.
7. Chilmonczyk Z. Models of 5-hydroxytryptamine receptors. A review. J. Pharm. Pharmacol. 47:1995;791-801.
8. Dougherty D.A. Cation-Π interactions in chemistry and biology: a new view of benzene, Phe, Tyr and Trp. Science. 271:1996;163-168.
9. 3 receptor ligands. Pharm. Biochem. Behav. 40:1991;1033-1040.
10. 3 receptor splice variants isolated from a mouse hippocampal cell line. Eur. J. Physiol. 432:1996;134-143.
11. 3 Receptors. 1992;59-88 Academic Press.
12. 3 receptor antagonists and a definition of a model for this receptor site. J. Med. Chem. 33:1990;1594-1600.
13. Hoyer D., Clarke D.E., Fozard J.R., Hartig P.R., Martin G.R., Mylecharane E.J., Saxena P.R., Humphrey P.P.A. VII. International union of pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol. Rev. 46:1994;157-203.
14. Hussy N., Lukas W., Jones K.A. Functional properties of a cloned 5-hydroxytryptamine ionotropic receptor subunit: comparison with native mouse receptors. J. Physiol. 481.2:1994;311-323.
15. Jullian N., Brabet I., Pin J.-P., Acher F. Agonist selectivity of mGluR1 and mGluR2 metabotropic receptors: a different environment but similar recognition of an extended glutamate conformation. J. Med. Chem. 42:1999;1546-1555.
16. Lankiewicz S., Lobitz N., Wetzel C.H.R., Rupprecht R., Gisselmann G., Hatt H. Molecular cloning, functional expression, and pharmacological characterization of 5-hydroxytryptamine3 receptor cDNA and its splice variants from guinea-pig. Mol. Pharmacol. 53:1998;202-212.
17. A receptors and gephyrin expression in cultured motoneurons. J. Neurosci. 19:1999;7434-7449.
18. 3A(b)) expressed in Xenopus laevis oocytes. Br. J. Pharmacol. 124:1998;1667-1674.
19. 3 serotonin receptor ligands. Neuropharmacology. 37:1998;1633-1641.
20. 3 receptor from NCB20 cells. J. Biol. Chem. 265:1990;13572-13577.
21. 3 receptors of the rat, mouse and guinea-pig superior cervical ganglion may be different. Br. J. Pharmacol. 102:1991;615-620.
22. Pribilla I., Takagi T., Langosch D., Bormann J., Betz H. The atypical M2 segment of the β subunit confers picrotoxinin resistance to inhibitory glycine receptor channels. EMBO J. 11:1992;4305-4311.
23. - current of acutely dissociated rat hippocampal neurons. Eur. J. Pharmacol. 367:1999;125-130.
24. 3 antagonists derived from aminopyridazine-type muscarinic M1 agonists. J. Med. Chem. 41:1998;311-317.
25. 3 receptor antagonist: synthesis and structure-activity relationships. J. Med. Chem. 35:1992;310-319.
26. 3 receptor ligand binding domain. J. Biol. Chem. 275:2000;5620-5625.
27. Supplisson S., Chesnoy-Marchais D. Glycine receptor β subunits play a critical role in potentiation of glycine responses by ICS-205,930. Mol. Pharmacol. 2000;. (in press).
28. 3R antagonists. Soc. Neurosci. Abs. 25:1999;202.
29. 3 receptor binding sites in rat brain. Eur. J. Pharmacol. 149:1988;397-398.
30. 3 receptor. J. Biol. Chem. 274:1999;5537-5541.
31. Ye J.H., Schaefer R., Wu W.H., Liu P.L., Zbuzek V.K., Mcardle J.J. Inhibitory effect of ondansetron on glycine response of dissociated rat hippocampal neurons. J. Pharmacol. Exp. Ther. 290:1999;104-111.
32. Zifa E., Fillion G. 5-Hydroxytryptamine receptors. Pharmacol. Rev. 44:1992;401-458.